...
首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >ITRAQ-based proteomic profiling of human serum reveals down-regulation of platelet basic protein and apolipoprotein B100 in patients with hematotoxicity induced by chronic occupational benzene exposure
【24h】

ITRAQ-based proteomic profiling of human serum reveals down-regulation of platelet basic protein and apolipoprotein B100 in patients with hematotoxicity induced by chronic occupational benzene exposure

机译:基于ITRAQ的人血清蛋白质组学分析揭示了慢性职业性苯暴露引起的血液中毒患者血小板碱性蛋白和载脂蛋白B100的下调

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Benzene is an important industrial chemical and an environmental contaminant, but the pathogenesis of hematotoxicity induced by chronic occupational benzene exposure (HCOBE) remains to be elucidated. To gain an insight into the molecular mechanisms and developmental biomarkers for HCOBE, isobaric tags for relative and absolute quantitation (iTRAQ) combined with two-dimensional liquid chromatography-tandem mass spectrometry (2D-LC-MS/MS) were utilized. Identification and quantitation of differentially expressed proteins between HCOBE cases and healthy control were thus made. Expressions of selected proteins were confirmed by western blot and further validated by ELISA. A total of 159 unique proteins were identified (≥95% confidence), and relative expression data were obtained for 141 of these in 3 iTRAQ experiments, with fifty proteins found to be in common among 3 iTRAQ experiments. Plasminogen (PLG) was found to be significantly up-regulated, whereas platelet basic protein (PBP) and apolipoprotein B100 (APOB100) were significantly down-regulated in the serum of HCOBE cases. Additionally, the altered proteins were associated with the molecular functions of binding, catalytic activity, enzyme regulator activity and transporter activity, and involved in biological processes of apoptosis, developmental and immune system process, as well as response to stimulus. Furthermore, differential expressions of PLG, PBP and APOB100 were confirmed by western blot, and the clinical relevance of PBP and APOB100 with HCOBE was validated by ELISA. Overall, our results showed that lowered expression of PBP and APOB100 proteins served as potential biomarkers of HCOBE, and may play roles in the benzene-induced immunosuppressive effects and disorders in lipid metabolism.
机译:苯是一种重要的工业化学品和环境污染物,但慢性职业性苯暴露(HCOBE)引起的血液毒性的发病机理仍有待阐明。为了深入了解HCOBE的分子机理和发育生物标志物,利用了相对和绝对定量(iTRAQ)的等压标记结合二维液相色谱-串联质谱(2D-LC-MS / MS)。因此,对HCOBE病例与健康对照之间差异表达的蛋白质进行了鉴定和定量。通过蛋白质印迹证实所选蛋白的表达,并通过ELISA进一步验证。在3个iTRAQ实验中,总共鉴定出159种独特蛋白质(可信度≥95%),并获得了141种相对表达数据,其中3种iTRAQ实验中共有50种蛋白质。在HCOBE患者的血清中,血浆纤溶酶原(PLG)被显着上调,而血小板碱性蛋白(PBP)和载脂蛋白B100(APOB100)被显着下调。另外,改变的蛋白质与结合的分子功能,催化活性,酶调节活性和转运蛋白活性有关,并参与凋亡的生物过程,发育和免疫系统过程以及对刺激的反应。此外,通过蛋白质印迹证实了PLG,PBP和APOB100的差异表达,并且通过ELISA验证了PBP和APOB100与HCOBE的临床相关性。总体而言,我们的结果表明,降低的PBP和APOB100蛋白表达可作为HCOBE的潜在生物标志物,并可能在苯诱导的免疫抑制作用和脂质代谢紊乱中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号